News & Events
2010
-
October 20, 2010Peretinoin(NIK-333)Data, the Results of the Clinical Pharmacology Study for Liver Gene Expression Profiles in Patients after Curative Therapy of Hepatocellular Carcinoma (HCC), To Be Presented at The 61st Annual Meeting of the American Association for the Study of Liver Diseases
-
September 13, 2010Peretinoin reduces recurrence risk of hepatocellular carcinoma after curative therapy
-
August 30, 2010Peretinoin(NIK-333)Data, the Results of the Phase II/III Trial for the Suppression of Recurrence of Hepatocellular Carcinoma (HCC), To Be Presented at the International Liver Cancer Association Annual Conference